These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8571953)

  • 1. Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.
    Neuhausen SL; Mazoyer S; Friedman L; Stratton M; Offit K; Caligo A; Tomlinson G; Cannon-Albright L; Bishop T; Kelsell D; Solomon E; Weber B; Couch F; Struewing J; Tonin P; Durocher F; Narod S; Skolnick MH; Lenoir G; Serova O; Ponder B; Stoppa-Lyonnet D; Easton D; King MC; Goldgar DE
    Am J Hum Genet; 1996 Feb; 58(2):271-80. PubMed ID: 8571953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.
    Neuhausen SL; Godwin AK; Gershoni-Baruch R; Schubert E; Garber J; Stoppa-Lyonnet D; Olah E; Csokay B; Serova O; Lalloo F; Osorio A; Stratton M; Offit K; Boyd J; Caligo MA; Scott RJ; Schofield A; Teugels E; Schwab M; Cannon-Albright L; Bishop T; Easton D; Benitez J; King MC; Ponder BA; Weber B; Devilee P; Borg A; Narod SA; Goldgar D
    Am J Hum Genet; 1998 Jun; 62(6):1381-8. PubMed ID: 9585613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families.
    Ikeda N; Miyoshi Y; Yoneda K; Shiba E; Sekihara Y; Kinoshita M; Noguchi S
    Int J Cancer; 2001 Jan; 91(1):83-8. PubMed ID: 11149425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation.
    Gayther SA; Warren W; Mazoyer S; Russell PA; Harrington PA; Chiano M; Seal S; Hamoudi R; van Rensburg EJ; Dunning AM; Love R; Evans G; Easton D; Clayton D; Stratton MR; Ponder BA
    Nat Genet; 1995 Dec; 11(4):428-33. PubMed ID: 7493024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.
    Johannsson O; Ostermeyer EA; Håkansson S; Friedman LS; Johansson U; Sellberg G; Brøndum-Nielsen K; Sele V; Olsson H; King MC; Borg A
    Am J Hum Genet; 1996 Mar; 58(3):441-50. PubMed ID: 8644702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families.
    Serova O; Montagna M; Torchard D; Narod SA; Tonin P; Sylla B; Lynch HT; Feunteun J; Lenoir GM
    Am J Hum Genet; 1996 Jan; 58(1):42-51. PubMed ID: 8554067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland.
    Sarantaus L; Huusko P; Eerola H; Launonen V; Vehmanen P; Rapakko K; Gillanders E; Syrjäkoski K; Kainu T; Vahteristo P; Krahe R; Pääkkönen K; Hartikainen J; Blomqvist C; Löppönen T; Holli K; Ryynänen M; Bützow R; Borg A; Wasteson Arver B; Holmberg E; Mannermaa A; Kere J; Kallioniemi OP; Winqvist R; Nevanlinna H
    Eur J Hum Genet; 2000 Oct; 8(10):757-63. PubMed ID: 11039575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds.
    Berman DB; Wagner-Costalas J; Schultz DC; Lynch HT; Daly M; Godwin AK
    Am J Hum Genet; 1996 Jun; 58(6):1166-76. PubMed ID: 8651293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families.
    Friedman LS; Szabo CI; Ostermeyer EA; Dowd P; Butler L; Park T; Lee MK; Goode EL; Rowell SE; King MC
    Am J Hum Genet; 1995 Dec; 57(6):1284-97. PubMed ID: 8533757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.
    Tonin PN; Mes-Masson AM; Futreal PA; Morgan K; Mahon M; Foulkes WD; Cole DE; Provencher D; Ghadirian P; Narod SA
    Am J Hum Genet; 1998 Nov; 63(5):1341-51. PubMed ID: 9792861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families.
    Simard J; Tonin P; Durocher F; Morgan K; Rommens J; Gingras S; Samson C; Leblanc JF; Bélanger C; Dion F
    Nat Genet; 1994 Dec; 8(4):392-8. PubMed ID: 7894492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis of the BRCA1 and BRCA2 genes in the Belgian patient population and identification of a Belgian founder mutation BRCA1 IVS5 + 3A > G.
    Claes K; Machackova E; De Vos M; Poppe B; De Paepe A; Messiaen L
    Dis Markers; 1999 Oct; 15(1-3):69-73. PubMed ID: 10595255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.
    Vehmanen P; Friedman LS; Eerola H; McClure M; Ward B; Sarantaus L; Kainu T; Syrjäkoski K; Pyrhönen S; Kallioniemi OP; Muhonen T; Luce M; Frank TS; Nevanlinna H
    Hum Mol Genet; 1997 Dec; 6(13):2309-15. PubMed ID: 9361038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer.
    Struewing JP; Brody LC; Erdos MR; Kase RG; Giambarresi TR; Smith SA; Collins FS; Tucker MA
    Am J Hum Genet; 1995 Jul; 57(1):1-7. PubMed ID: 7611277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing.
    Unger MA; Nathanson KL; Calzone K; Antin-Ozerkis D; Shih HA; Martin AM; Lenoir GM; Mazoyer S; Weber BL
    Am J Hum Genet; 2000 Oct; 67(4):841-50. PubMed ID: 10978226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation analysis of the BRCA1 gene in ovarian cancers.
    Takahashi H; Behbakht K; McGovern PE; Chiu HC; Couch FJ; Weber BL; Friedman LS; King MC; Furusato M; LiVolsi VA
    Cancer Res; 1995 Jul; 55(14):2998-3002. PubMed ID: 7606717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis of eight breast-ovarian cancer families with suspected BRCA1 mutations.
    Couch FJ; Garber J; Kiousis S; Calzone K; Hauser ER; Merajver SD; Frank TS; Boehnke M; Chamberlain JS; Collins FS
    J Natl Cancer Inst Monogr; 1995; (17):9-14. PubMed ID: 8573462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA1 and BRCA2 genes: role in hereditary breast and ovarian cancer in Italy.
    Santarosa M; Dolcetti R; Magri MD; Crivellari D; Tibiletti MG; Gallo A; Tumolo S; Della Puppa L; Furlan D; Boiocchi M; Viel A
    Int J Cancer; 1999 Sep; 83(1):5-9. PubMed ID: 10449599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.
    Górski B; Byrski T; Huzarski T; Jakubowska A; Menkiszak J; Gronwald J; Pluzańska A; Bebenek M; Fischer-Maliszewska L; Grzybowska E; Narod SA; Lubiński J
    Am J Hum Genet; 2000 Jun; 66(6):1963-8. PubMed ID: 10788334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.